# CONTRAFECT Corp

CONTRAFECT Corp is a company headquartered in Yonkers, NY, United States.

## Company overview

- **Legal name:** CONTRAFECT Corp
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Yonkers, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001478069

## About

CONTRAFECT Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001478069, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-31, it reported net income of USD -65,153,000; total assets of USD 20,679,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$65.2M (USD -65,153,000)
- **Total assets:** $20.7M (USD 20,679,000)
- **Cash and equivalents:** $8.9M (USD 8,907,000)
- **Operating cash flow:** -$46.0M (USD -45,974,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$20.3M (USD -20,282,000)
- **Total assets:** $66.8M (USD 66,762,000)
- **Cash and equivalents:** $16.7M (USD 16,654,000)
- **Operating cash flow:** -$41.1M (USD -41,125,000)

### FY2020 (period ended 2020-12-31)

- **Net income:** -$28.2M (USD -28,155,673)
- **Total assets:** $51.1M (USD 51,115,579)
- **Cash and equivalents:** $15.5M (USD 15,484,899)
- **Operating cash flow:** -$33.2M (USD -33,186,315)
- **Later filings:** Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2019 (period ended 2019-12-31)

- **Net income:** -$12.8M (USD -12,794,493)
- **Total assets:** $35.0M (USD 35,008,709)
- **Cash and equivalents:** $24.2M (USD 24,184,140)
- **Operating cash flow:** -$27.4M (USD -27,427,893)
- **Later filings:** Net income, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2023-12-05 — period 2023-12-04 — 8-K
- Form 8-K — filed 2023-11-15 — period 2023-11-15 — 8-K
- Form 10-Q — filed 2023-11-14 — period 2023-09-30 — 10-Q
- Form 8-K — filed 2023-11-08 — period 2023-11-07 — 8-K
- Form S-1 — filed 2023-10-30 — S-1
- Form S-1 — filed 2023-10-24 — S-1
- Form 8-K — filed 2023-09-29 — period 2023-09-21 — 8-K
- Form DEF 14A — filed 2023-09-25 — period 2023-10-23 — DEF 14A
- Form 8-K — filed 2023-08-18 — period 2023-08-15 — 8-K
- Form 10-Q — filed 2023-08-14 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-08-14 — period 2023-08-14 — 8-K
- Form 8-K — filed 2023-07-25 — period 2023-07-21 — 8-K

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/contrafect-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology